Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Suzetrigine

🥰Excellent
Catalog No. T69552Cas No. 2649467-58-1
Alias VX-548

Suzetrigine(VX-548) is an orally active and specific NaV1.8 inhibitor. Suzetrigine has analgesic activity and can be used to study acute pain and neurotransmission.

Suzetrigine

Suzetrigine

🥰Excellent
Purity: 99.27%
Catalog No. T69552Alias VX-548Cas No. 2649467-58-1
Suzetrigine(VX-548) is an orally active and specific NaV1.8 inhibitor. Suzetrigine has analgesic activity and can be used to study acute pain and neurotransmission.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$53In StockIn Stock
5 mg$116In StockIn Stock
10 mg$173In StockIn Stock
25 mg$281In StockIn Stock
50 mg$482In StockIn Stock
100 mg$786In StockIn Stock
200 mg$1,080In StockIn Stock
1 mL x 10 mM (in DMSO)$120In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.27%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Suzetrigine(VX-548) is an orally active and specific NaV1.8 inhibitor. Suzetrigine has analgesic activity and can be used to study acute pain and neurotransmission.
Targets&IC50
Nav1.8 (human):0.68 ± 0.16 nM, NaV1.8:0.7 nM, NaV1.8 (dog):740 nM, NaV1.8 (monkey):0.75 nM, NaV1.8 (rabbit):52 nM, NaV1.8 (rat):56 nM, NaV1.8 (mouse):210 nM
In vivo
As compared with placebo, Suzetrigine at the highest dose (a 100-mg oral loading dose of Suzetrigine, followed by a 50-mg maintenance dose every 12 hours), but not at lower doses (a 20-mg loading dose, followed by a 10-mg maintenance dose every 12 hours), reduced acute pain over a period of 48 hours after abdominoplasty or bunionectomy.[1]
SynonymsVX-548
Chemical Properties
Molecular Weight473.39
FormulaC21H20F5N3O4
Cas No.2649467-58-1
SmilesC(NC=1C=C(C(N)=O)N=CC1)(=O)[C@H]2[C@@H]([C@H](C)[C@@]([C@@](F)(F)F)(C)O2)C3=C(OC)C(F)=C(F)C=C3
Storage & Solubility Information
Storagestore at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 161 mg/mL (340.1 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1124 mL10.5621 mL21.1242 mL105.6212 mL
5 mM0.4225 mL2.1124 mL4.2248 mL21.1242 mL
10 mM0.2112 mL1.0562 mL2.1124 mL10.5621 mL
20 mM0.1056 mL0.5281 mL1.0562 mL5.2811 mL
50 mM0.0422 mL0.2112 mL0.4225 mL2.1124 mL
100 mM0.0211 mL0.1056 mL0.2112 mL1.0562 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Suzetrigine | purchase Suzetrigine | Suzetrigine cost | order Suzetrigine | Suzetrigine chemical structure | Suzetrigine in vivo | Suzetrigine formula | Suzetrigine molecular weight